Suppr超能文献

宫颈癌领域的长链非编码RNA(综述)

Long non-coding RNAs on the stage of cervical cancer (Review).

作者信息

Dong Junxue, Su Manman, Chang Weiqin, Zhang Kun, Wu Shuying, Xu Tianmin

机构信息

Second Affiliated Hospital, Jilin University, Changchun, Jilin 130000, P.R. China.

College of Pharmacy, Jilin University, Changchun, Jilin 130000, P.R. China.

出版信息

Oncol Rep. 2017 Oct;38(4):1923-1931. doi: 10.3892/or.2017.5905. Epub 2017 Aug 14.

Abstract

Cervical cancer is one of most malignant gynecological tumors. However, effective means for diagnosing and treating cervical cancer have yet to be identified. A few decades ago, long non-coding RNAs (lncRNAs) were regarded as useless parts of the genome, however, increasing data have demonstrated the importance of lncRNAs in the diagnosis and treatment of cervical cancers. The aim of the present study is to summarize the role(s) of HOTAIR, MALAT1, CCAT2, SPRY4-IT1, RSU1P2, CCHE1, lncRNA-EBIC and PVT1. Approximately 14 lncRNAs are involved in cervical cancer and several important proteins, miRNAs and other molecules and play crucial roles in a few traditional signaling pathways that have been proven to be related to those lncRNAs. In conclusion, lncRNAs may be useful as exact treatment targets and diagnostic biomarkers for improving therapies in cervical cancer patients and lncRNAs may contribute to effective diagnosis and treatment methods for cervical cancer.

摘要

宫颈癌是最常见的妇科恶性肿瘤之一。然而,尚未找到诊断和治疗宫颈癌的有效方法。几十年前,长链非编码RNA(lncRNAs)被认为是基因组中的无用部分,然而,越来越多的数据表明lncRNAs在宫颈癌的诊断和治疗中具有重要作用。本研究的目的是总结HOTAIR、MALAT1、CCAT2、SPRY4-IT1、RSU1P2、CCHE1、lncRNA-EBIC和PVT1的作用。大约14种lncRNAs参与宫颈癌以及几种重要的蛋白质、miRNAs和其他分子,并在一些已被证明与这些lncRNAs相关的传统信号通路中发挥关键作用。总之,lncRNAs可能作为精确的治疗靶点和诊断生物标志物,用于改善宫颈癌患者的治疗,并且lncRNAs可能有助于宫颈癌的有效诊断和治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验